Menu
GeneBe

rs77565483

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000098.3(CPT2):c.1767G>A(p.Thr589=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00329 in 1,614,210 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. TSTLS589T?) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.0097 ( 14 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 31 hom. )

Consequence

CPT2
NM_000098.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.78
Variant links:
Genes affected
CPT2 (HGNC:2330): (carnitine palmitoyltransferase 2) The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 1-53213385-G-A is Benign according to our data. Variant chr1-53213385-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 92432.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.78 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00972 (1480/152322) while in subpopulation AFR AF= 0.0248 (1031/41564). AF 95% confidence interval is 0.0235. There are 14 homozygotes in gnomad4. There are 699 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CPT2NM_000098.3 linkuse as main transcriptc.1767G>A p.Thr589= synonymous_variant 5/5 ENST00000371486.4
CPT2NM_001330589.2 linkuse as main transcriptc.1698G>A p.Thr566= synonymous_variant 5/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CPT2ENST00000371486.4 linkuse as main transcriptc.1767G>A p.Thr589= synonymous_variant 5/51 NM_000098.3 P1
ENST00000629810.1 linkuse as main transcriptn.88C>T non_coding_transcript_exon_variant 1/35

Frequencies

GnomAD3 genomes
AF:
0.00971
AC:
1478
AN:
152204
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0248
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0150
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00203
Gnomad OTH
AF:
0.0129
GnomAD3 exomes
AF:
0.00422
AC:
1062
AN:
251482
Hom.:
6
AF XY:
0.00366
AC XY:
498
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.0253
Gnomad AMR exome
AF:
0.00653
Gnomad ASJ exome
AF:
0.00883
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000294
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00225
Gnomad OTH exome
AF:
0.00929
GnomAD4 exome
AF:
0.00262
AC:
3834
AN:
1461888
Hom.:
31
Cov.:
31
AF XY:
0.00247
AC XY:
1796
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.0250
Gnomad4 AMR exome
AF:
0.00796
Gnomad4 ASJ exome
AF:
0.00811
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000267
Gnomad4 FIN exome
AF:
0.000580
Gnomad4 NFE exome
AF:
0.00173
Gnomad4 OTH exome
AF:
0.00634
GnomAD4 genome
AF:
0.00972
AC:
1480
AN:
152322
Hom.:
14
Cov.:
33
AF XY:
0.00939
AC XY:
699
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.0248
Gnomad4 AMR
AF:
0.0150
Gnomad4 ASJ
AF:
0.00893
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.000941
Gnomad4 NFE
AF:
0.00203
Gnomad4 OTH
AF:
0.0128
Alfa
AF:
0.00681
Hom.:
7
Bravo
AF:
0.0124
Asia WGS
AF:
0.00346
AC:
13
AN:
3478
EpiCase
AF:
0.00284
EpiControl
AF:
0.00308

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxSep 15, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 14, 2013- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 06, 2019Variant summary: CPT2 c.1767G>A alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0042 in 251482 control chromosomes in the gnomAD database, including 6 homozygotes. The observed variant frequency is approximately 3-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in CPT2 causing Carnitine Palmitoyltransferase II Deficiency phenotype (0.0016), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1767G>A in individuals affected with Carnitine Palmitoyltransferase II Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cites the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
Carnitine palmitoyltransferase II deficiency Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Carnitine palmitoyl transferase II deficiency, neonatal form Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Carnitine palmitoyl transferase II deficiency, myopathic form;C1833511:Carnitine palmitoyl transferase II deficiency, severe infantile form;C1833518:Carnitine palmitoyl transferase II deficiency, neonatal form;C3280160:Encephalopathy, acute, infection-induced, susceptibility to, 4 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 24, 2021- -
Carnitine palmitoyl transferase II deficiency, myopathic form Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Encephalopathy, acute, infection-induced, susceptibility to, 4 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Carnitine palmitoyl transferase II deficiency, severe infantile form Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 21, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
Cadd
Benign
0.30
Dann
Benign
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77565483; hg19: chr1-53679057; API